30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Michael Severino

Track

Insider profile

Currently holds a position at Abbvie Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 90% 68% 82%
Transactions
22 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Vice Chairman Abbvie Inc Dec. 13, 2018 -
Executive Vice President - Research & Development, Chief Scientific Officer Abbvie Inc May 15, 2014 - Dec. 13, 2018
Michael Severino's trades of Abbvie Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-25 2022-05-23
US Abbvie Inc (ABBV)
S Sale
81,965 -5.3%
408.68
US$169,353 		81,965 -5.3% 408.68 US$169,353
2022-05-25 2022-05-23
US Abbvie Inc (ABBV)
S Sale
21,564 -38.5%
111.51
US$2,296,703 		21,564 -38.5% 111.51 US$2,296,703
2022-05-18 2022-05-17
US Abbvie Inc (ABBV)
S Sale
51,994 -42.5%
419.28
US$306,297 		51,994 -42.5% 419.28 US$306,297
2022-05-18 2022-05-17
US Abbvie Inc (ABBV)
S Sale
54,279 -26.0%
154.49
US$8,385,563 		54,279 -26.0% 154.49 US$8,385,563
2022-05-18 2022-05-17
US Abbvie Inc (ABBV)
S Sale
43,621 -17.3%
153.43
US$6,692,770 		43,621 -17.3% 153.43 US$6,692,770
2022-05-18 2022-05-16
US Abbvie Inc (ABBV)
S Sale
400 -0.3%
155.44
US$62,176 		400 -0.3% 155.44 US$62,176
2022-05-18 2022-05-16
US Abbvie Inc (ABBV)
S Sale
53,327 -25.9%
154.80
US$8,255,020 		53,327 -25.9% 154.80 US$8,255,020
2022-05-18 2022-05-16
US Abbvie Inc (ABBV)
S Sale
46,273 -18.4%
154.04
US$7,127,893 		46,273 -18.4% 154.04 US$7,127,893
2022-05-10 2022-05-10
US Abbvie Inc (ABBV)
S Sale
48,591 -24.2%
152.83
US$7,426,163 		48,591 -24.2% 152.83 US$7,426,163
2022-05-10 2022-05-10
US Abbvie Inc (ABBV)
S Sale
28,536 -12.4%
152.24
US$4,344,321 		28,536 -12.4% 152.24 US$4,344,321
2022-05-10 2022-05-10
US Abbvie Inc (ABBV)
S Sale
22,873 -9.1%
151.16
US$3,457,483 		22,873 -9.1% 151.16 US$3,457,483
2022-05-10 2022-05-09
US Abbvie Inc (ABBV)
S Sale
21,071 -12.2%
151.42
US$3,190,571 		21,071 -12.2% 151.42 US$3,190,571
2022-05-10 2022-05-09
US Abbvie Inc (ABBV)
S Sale
31,714 -15.5%
150.63
US$4,777,080 		31,714 -15.5% 150.63 US$4,777,080
2022-05-10 2022-05-09
US Abbvie Inc (ABBV)
S Sale
47,215 -18.7%
149.53
US$7,060,059 		47,215 -18.7% 149.53 US$7,060,059
2022-05-10 2022-05-06
US Abbvie Inc (ABBV)
S Sale
13,836 -8.3%
151.78
US$2,100,028 		13,836 -8.3% 151.78 US$2,100,028
2022-05-10 2022-05-06
US Abbvie Inc (ABBV)
S Sale
45,988 -21.7%
151.13
US$6,950,166 		45,988 -21.7% 151.13 US$6,950,166
2022-05-10 2022-05-06
US Abbvie Inc (ABBV)
S Sale
40,176 -15.9%
150.10
US$6,030,418 		40,176 -15.9% 150.10 US$6,030,418
2020-11-06 2020-11-04
US Abbvie Inc (ABBV)
S Sale
90,679 -57.4%
93.61
US$8,488,461 		90,679 -57.4% 93.61 US$8,488,461
2018-08-21 2018-08-17
US Abbvie Inc (ABBV)
S Sale
29,200 -26.2%
97.91
US$2,859,109 		29,200 -26.2% 97.91 US$2,859,109
2018-08-21 2018-08-17
US Abbvie Inc (ABBV)
S Sale
20,800 -15.7%
96.97
US$2,016,951 		20,800 -15.7% 96.97 US$2,016,951
2018-03-02 2018-02-28
US Abbvie Inc (ABBV)
S Sale
2,643 -2.0%
117.93
US$311,684 		2,643 -2.0% 117.93 US$311,684
2017-11-13 2017-11-10
US Abbvie Inc (ABBV)
S Sale
25,633 -18.2%
94.69
US$2,427,212 		25,633 -18.2% 94.69 US$2,427,212